AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis

Experimental Nephrology

Volumn 6, Issue 2, 1998, Pages 112-120

  Wolf, Gunter ^a,b   Schneider, Andre ^a   Helmchen, Udo ^b   Stahl, Rolf A K ^a  

^a Division of Nephrology   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Angiotensin II; Anti Thy 1 nephritis; Irbesartan; Losartan

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; IMMUNOBLOTTING; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GLOMERULUS; LEWIS RAT; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; RABBIT; WISTAR RAT;

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANTIBODY; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; IMMUNOGLOBULIN G; IRBESARTAN; LOSARTAN; LYMPHOCYTE ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; RENIN; TETRAZOLE DERIVATIVE;

ANIMALS; ANTIBODIES; ANTIHYPERTENSIVE AGENTS; ANTILYMPHOCYTE SERUM; BIPHENYL COMPOUNDS; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; LOSARTAN; MALE; POLYMERASE CHAIN REACTION; RABBITS; RATS; RATS, INBRED LEW; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN; TETRAZOLES;

EID: 0031596759     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Yamamoto T, Wilson CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage m the rat. Kidney Int 1987;32:514-525.
2. Bagchus WM, Hoedemaker PJ, Rozing J, Bakker WW: Glomerulonephntis induced by monoclonal ant-thy 1.1 antibodies. A sequential and ultrastructural stud} in the rat. Lab Invest 1986;55:680-687.
3. Johnson RJ, Pntzl P, Iida H, Alpers CE: Platelet-complement interactions m mesangial proliferative nephritis in the rat. Am J Palhol 1991;138:313-321.
4. Stahl RAK, Thaiss F, Kahf S, Schoeppe W, Helmchen UM: Immune-mediated mesanigal cell injury-biosynthesis and function of prostanoids. Kidney Int 1990;38:273-281.
5. Stahl RAK, Thasss F, Disser M, Heimchen U, Hora K, Schlöndorff D: Increased expression of monocyte chemoattractarnt protein-1 in antitihymocyte antibody-induced glomerulonephritis. Kidney Int 1993;44:1036-1047.
6. 1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymochte antibody-induced glomerular injury J Am Soc Nephrol 1996:897-905
7. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen U, Stahl RAK: Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephntis. Kidney Int 1997;51:770-776.
8. Maschio G, Albern D, Janin G, Locatelli F, Mann JE, MoEolese M, Ponticelli C, Ritz E, Zuchelh P: Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.
9. Jardine AG: Angiotensin II and glomerulonephntis. J Hypertens 1995;13:487-493.
10. Matsusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol 1996;7:2025-2043.
11. Wolf G: Vasoactive substances as regulators of renal growth. Exp Nephrol 1993;1:141-151.
12. Diamond JR, Anderson S: Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin 1 converting enzyme inhibition. Am J Pathol 1990;137:1323-1332.
13. Ishidoya S, Momssey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996;49:1110-1119.
14. Goetzl EJ, Klickstein LB, Watt KWK, Wintroub BU: The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. Biochem Biophys Res Commun 1980;97:1097-1102.
15. Farber HW, Center DM, Rounds S, Danilov SM: Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur Heart J 1990;11(suppl B): 100-107.
16. AI Kim J, Berliner JA, Nadler JL: Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun 1996;226:862-868.
17. 1 subtype angiotensin II antagonist. J Pharmacol Exp Ther 1993;265:826-834.
18. Zia F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS: The angiotensin antagonist, irbesartan, reduces renal injury in experimental chronic renal failure, Kidney Int 1996;50(suppl 57):132-136.
19. Bauer JH, Reams GP: The angiotensin II type 1 receptor antagonists. Arch Intern Med 1995;155:1361-1368.
20. Greenlee WJ, Wexler RR: Medical chemistry of angiotensin II antagonists: in Saavedra JM, Timinermans PBMWM (eds): Angiotensin Receptors. New York, Plenum Press. 1994, pp 67-93.
21. Stoscheck CM: Quantitation of proteins. Meth Enzymol 1990;182:50-68.
22. Wenzel UO, Fouqueray B, Grandaliano G, Kim YS, Karatmitsos C, VaJente AJ, Abboud HE: Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. Circ Res 1995;77:503-509.
23. Cattell V: Macrophages in acute glomerular inflammation. Kidney Int 1994;45:945-952.
24. Schlöndorff D: The role of chemokines in the initiation and progression of renal disease. Kidney Int 1995;47(suppl 49):44-47.
25. Brown Z, Robson RL, Westwick J: Regulation and expression of chemokines: Potential role in glomerulonephritis. J Leukocyte Biol 1996;59:75-80.
26. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montmaro V, Marra F, Schena FP: Monocyte chemotactic peptide-1 expression in acute and chronic human nephrites: A pathogenetic role in interstitial monocyte recruitment. J Am Soc Nephrol 1996;7:906-913.
27. Noms M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A: Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patient swith lupus nephritis. Lab Invest 1995;73:804-809.
28. Luckow Bm Wolf G, Schlöndorff D: The monocyte chemoattractant protein 1; in Schlöndorff D, Bonventre JV (eds): Molecular Nephrology. New York, Dekker, 1995, pp 653-671.
29. Wang DL, Wung ES, Shyy YJ, Lin CF, Chao YJ, Usami S, Chien S: Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Circ Res 1995;77:294-302.
30. Harris RC, Kondo S, Yasuda T: Mechanical stress-cell function relationships in renal cells. Exp Nephrol 1997;5:263-270.
31. Timmermans V, Peake PW, Charlesworth JA, Macdonald GJ, Pawlak MA: Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis. Kidney Int 1990;38:518-524.
32. Ruiz-Ortega M, Bustos C, Egido J: Angiotensin II triggers monocyte chemoattractant protein-I (MCP-1), transforming growth factor (TGF-β1) and matrix protein gene expression in mesangial cells and interstitial renal fibroblasts (abstract). Nephrol Dial Transplant 1996;11:58.
33. KimYS, Bhandari B, Abboud HE: Angiotensin II (ANGII) stimulates monocyte chemoattractant protein-1 (MCP-1) expression in rat mesangial cells (abstract). J Am Soc Nephrol 1996;7:1737.
34. Satnano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlöndorff D: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-I, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G: Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993;92:1564-1571.
35. phox is a critical component of the superoxide-generating NADH/ NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317-23321.
36. Hemändez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, Egido J: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997;95:1532-1541.
37. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Heimchen U, Stahl RAK: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin tvpe 2 receptor. J Clin Invest 1997;100:1047-1058.